Welcome to our dedicated page for Rocket Lab SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rocket Lab's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rocket Lab's regulatory disclosures and financial reporting.
Merline A. Saintil reported reported sales of common stock under Rule 144. The filing lists four transactions totaling 37,500 shares sold on specific dates: 15,000 shares on 12/12/2025 for $975,000.00; 5,000 shares on 12/17/2025 for $272,064.50; 5,000 shares on 12/19/2025 for $324,743.50; and 12,500 shares on 01/14/2026 for $1,124,368.50.
The broker listed is Morgan Stanley Smith Barney LLC and the transactions are described as sales of common stock; the filing notes restricted stock vesting under a registered plan with a referenced date 06/14/2023.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported multiple open-market sales of common stock on March 2, 2026. The transactions, made under a pre-arranged Rule 10b5-1 plan, sold 62,744 shares mainly to cover tax withholding from vested restricted stock units. Sale prices were reported as weighted averages, with underlying trades occurring in ranges between $66.4700 and $70.9450 per share.
Rocket Lab Corp’s Chief Operations Officer Frank Klein reported open-market sales of 81,250 shares of common stock on March 2 and 4, 2026. These transactions were executed as Rule 10b5-1 trading plan sales, including a sell-to-cover sale to satisfy tax withholding tied to vested restricted stock units.
The shares were sold at weighted-average prices reported in ranges from $66.47 to $73.99 per share across multiple trades. After these transactions, Klein directly held 1,088,237 Rocket Lab shares, reflecting his remaining equity stake in the company.
Rocket Lab Corp senior vice president and general counsel Arjun Kampani reported selling a total of 52,472 shares of Rocket Lab common stock in open-market transactions. The sales occurred on March 2 and March 4, 2026 at weighted-average prices generally in the mid-$60s to low-$70s per share. Part of the sale was a sell-to-cover transaction under a Rule 10b5-1 election to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units. The remaining sales occurred automatically under a Rule 10b5-1 trading plan adopted on September 19, 2025. After these trades, Kampani directly owned 397,988 Rocket Lab common shares.
Rocket Lab Corp CEO Peter Beck reported multiple stock sales linked to tax withholding. On March 2, 2026, he sold a total of 18,857 shares of common stock in open-market transactions under a pre-arranged Rule 10b5-1 plan.
According to the disclosure, these were “sell-to-cover” trades to satisfy applicable tax withholding obligations from vesting and settlement of previously granted restricted stock units. The sales were executed at weighted-average prices, with underlying trade prices ranging from $66.47 to $70.945 per share. After these sales, Beck directly owned 884,085 Rocket Lab shares.
Frank Klein reported restricted stock unit holdings and recent dispositions of common stock in a Form 144 disclosure. The filing lists 36,768 Restricted Stock Units with an effective date of 03/01/2026 and shows common shares sold during the past three months: 44,482 shares on 03/01/2026 and 100,000 shares on 01/02/2026. The trades are reported through Morgan Stanley Smith Barney LLC on 03/04/2026.
Arjun Kampani filed a Form 144 reporting the proposed sale of 23,711 Restricted Stock Units.
The excerpt also records a sale of 28,761 common shares on 03/01/2026 for an aggregate of $2,001,475.11, and lists Morgan Stanley Smith Barney LLC as the executing broker.
Adam Spice reports a proposed sale of 114,845 common shares tied to restricted stock vesting dated 03/01/2026. The filing excerpt also shows sales of 1,365,665 common shares on 01/05/2026 for $103,112,350.76 as transactions during the past three months.
The notice lists the transaction type as Restricted Stock Vesting and identifies the broker/dealer and listing market as NASDAQ. Timing and cash‑flow treatment for the proposed sale are presented in the excerpt.
RKLB submitted a notice under Section 144 reporting a proposed sale of 81,250 common shares tied to restricted stock vesting dated 03/01/2026.
The filing also discloses a prior sale by Frank Klein of 100,000 common shares on 01/02/2026 for $7,294,980. The broker/dealer listed is Morgan Stanley Smith Barney LLC Executive Services.
Rocket Lab (RKLB) reporting a Form 144 notice related to restricted stock vesting dated 03/01/2026. The filing lists 38,685 and 13,787 shares tied to restricted stock vesting with the issuer on that date. The entries reflect planned dispositions by a broker-dealer account.